Abeona Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Abeona Therapeutics Inc. (Nasdaq: ABEO) has successfully raised $25 million through a registered direct offering under Nasdaq rules. The funds were primarily raised to support the launch preparations for the Company's EB-101 Biologics License Application (BLA) submission and potential approval. Abeona entered into definitive agreements with existing institutional investors, issuing and selling 3..

• format_list_bulleted BS
• · 2023. 7. 4.
• textsms

NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering

NRx Pharmaceuticals has announced the completion of its registered direct offering for 9,670,002 shares of common stock at $0.65 per share, resulting in gross proceeds of approximately $6.28 million before deducting placement agent fees and other expenses. The company intends to use net proceeds from the offering for working capital and general corporate purposes, as well as potentially using it..

• format_list_bulleted BS
• · 2023. 6. 11.
• textsms

Elevation Oncology Announces Pricing of $50 Million Public Offering

Elevation Oncology, a company focused on developing selective cancer therapies for solid tumors with significant unmet medical needs, has announced the pricing of an underwritten public offering of common stock and pre-funded warrants to purchase shares of common stock. The combined offering price is $2.2500 per share of common stock and accompanying warrant and $2.2499 per pre-funded warrant an..

• format_list_bulleted BS
• · 2023. 6. 10.
• textsms